PharmaCyte Biotech, Inc. (PMCB)
Nasdaq: PMCB · Biological Products, (No Diagnostic Substances) · Las Vegas, NV · filing with the SEC since 2001
Who runs PharmaCyte Biotech, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Silverman Joshua
CEO and President. First filing Aug 2022, latest Jan 7, 2026, 1 filing in all.
Officers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
15 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Silverman Joshua | CEO and President | Aug 2022 | Jan 7, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Abecassis Michael M | director | Aug 2021 | Jul 17, 2026 | none |
| Schechter Jonathan | director | Aug 2022 | Jul 17, 2026 | none |
| Walker Wayne Remell | director | Dec 2022 | Jul 17, 2026 | none |
| Weinstein Robert | director | Nov 2022 | Jul 17, 2026 | none |
Earlier names on the record10, newest filing first
Trujillo Carlos · officer · last filing Nov 2023Allen Daniel · director · last filing Dec 2022Farb Daniel Stuart · director · last filing Dec 2022Stover Jack E · director · last filing Aug 2022Loehr Matthias · director · last filing Apr 2022Waggoner Kenneth L. · officer · last filing Aug 2021Crabtree Gerald W · officer · last filing Aug 2021Yuen Thomas C K · director · last filing Aug 2021Liquard Thomas · director · last filing Aug 2021Tong Raymond Cf · director · last filing Aug 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.